Pierda peso con un plan diseñado para usted.
GLP-1 medication prescribed by U.S. licensed doctors, personalized to your body. Take a free online assessment to see if you qualify.
This site contains affiliate links. If you enroll through a link on this page, Telehealth FX may earn a commission at no extra cost to you. Full disclosure
Compare Tratamientos y Promociones del Primer Mes
Doctor-prescribed GLP-1 & GIP treatments delivered cold to your door. Get started from just $99 for your primer mes with zero doctor consultation fees.
Compounded Semaglutide
Weekly Subcutaneous Injection
- ✓Doctor consult & evaluation included ($0 fee)
- ✓Full administration kit (syringes & wipes)
- ✓Free overnight temperature-controlled shipping
- ✓100% money-back guarantee if not approved
Compounded Tirzepatide
Weekly Subcutaneous Injection (GLP-1 + GIP)
- ✓Dual GIP/GLP-1 receptor agonist therapy
- ✓Up to 22.5% body weight reduction in trials
- ✓Prescriber review & supplies included
- ✓No contracts — pause or cancel anytime
Semaglutide Tablets
Daily Sublingual Oral Dissolving Tablet
- ✓No injections — dissolves under the tongue
- ✓No refrigeration needed (ideal for travel)
- ✓Doctor consultation & continuo care included
- ✓Free express home delivery
Tirzepatide Tablets
Daily Dual GLP-1 + GIP Sublingual Tablet
- ✓Needle-free dual-action incretin formula
- ✓Metabolic acceleration & appetite suppression
- ✓Clinician review & adjustments included
- ✓Cancel anytime with zero penalties
Comience en minutos desde casa
Affiliate link — we may earn a commission if you enroll. This does not affect the price you pay.
Pérdida de peso con base científica
Lo que dicen los pacientes
"I've tried everything — diets, gym programs, supplements. SkinnyRx was the first thing that actually worked. Down 34 lbs and my energy is through the roof."
"The app makes it so easy to stay on track. I love being able to message my doctor directly. The medication combined with the support changed everything."
"I was skeptical about online weight loss, but my doctor was amazing. She adjusted my dosage perfectly and I've never felt better. Worth every penny."
Individual experiences vary. These patients consented to share their stories. Results are not typical and depend on many individual factors including starting weight, adherence, diet, and exercise.
How GLP-1 medications support weight loss.
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after eating. It signals your brain to feel full and helps regulate blood sugar levels — two critical factors in sustainable weight management.
GLP-1 receptor agonist medications mimic this natural hormone, helping reduce appetite and food intake. Clinical trials have shown significant weight loss results when combined with lifestyle changes and medical supervision.
SkinnyRx connects you with doctors who specialize in these treatments. Your physician evaluates your health profile and, if appropriate, prescribes a GLP-1 medication customized to your needs from a licensed compounding pharmacy.
A licensed physician will determine whether a GLP-1 medication is right for you based on your health assessment and medical history.
Preguntas frecuentes
Ready to start your weight loss journey?
Take the free online assessment. A licensed doctor will review your information and create a plan personalized for your body.
Comenzar — It's FreePeer-Reviewed Clinical & Regulatory References
- Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). The New England Journal of Medicine, 384(11), 989–1002. [PubMed PMID: 33567185 ↗]
- Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). The New England Journal of Medicine, 387(3), 205–216. [PubMed PMID: 35658024 ↗]
- U.S. Food and Drug Administration (FDA). (2024). Human Drug Compounding: Section 503A of the Federal Food, Drug, and Cosmetic Act. 21 U.S.C. § 353a. [FDA Compounding Regulations & Laws ↗]
- Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT Trial). The New England Journal of Medicine, 389(24), 2221–2232. [PubMed PMID: 37952131 ↗]
- United States Pharmacopeial Convention. (2023). USP General Chapter 797: Pharmaceutical Compounding — Sterile Preparations. [FDA & USP Compounding Standards ↗]